The past two decades have seen a large volume of international finance from developed country governments, multilateral development banks, and private philanthropic organizations allocated to tackle global disease challenges.
But the overall environment for raising such international finance for global health priorities is getting tougher. This is despite the enormous humanitarian, social and economic benefits from funding measures to prevent pandemics, limit the spread of infectious disease, and slow the spread of antimicrobial resistance (AMR).
Amid an increasingly complex and challenging financing environment, the primary objective of this conference is to delve into the critical factors and processes – political, economic, and institutional –which shape current decisions regarding international financing for global health priorities.
The conference explores avenues for strengthening decision-making collectively across the international health and finance communities and includes discussion of the findings of a recent research project conducted by Chatham House which specifically examines these issues.
Through these deliberations, the conference seeks to foster a holistic view of the issues and institutions that determine the international financing of global health and contribute to practical steps for improving decision-making processes going forward.
